Press Room | PerkinElmer
Cookies on PerkinElmer
PerkinElmer uses cookies to ensure that we give you the best experience possible on our website. This may include cookies from third party websites. If you continue without changing your settings, we will assume that you consent to receive cookies from this website. You can change your cookie settings at any time. To learn more, please review our cookie policy, which includes information on how to manage your cookies.
Press Conference

Recent Media Coverage

Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.

Data-driven Drug Development

Drug development is facing change from both technological pressures, including the use of AI and machine learning, and new regulations, which are transforming the way electronic records are created and stored for clinical trials.

PerkinElmer Vanadis NIPT Receives CE-IVD Mark

The test, designed for noninvasive prenatal screening for trisomies 21, 18, and 13, with Y chromosome testing as an optional marker, has been validated in an external clinical study in France.

Navigating the 3Vs of Big Data: Volume, Velocity, Variety

David Wang, general manager of Informatics, explains how scientists can harness valuable information quickly to achieve better, faster outcomes—and expedite the drug discovery process—by taking "the 3Vs" into account.

Diagnosing Disease X

EUROIMMUN's Dr. Konstanze Stiba discusses the challenges associated with developing a diagnostic for "Disease X," which represents newly emerging pathogens that present a significant public health risk - with the potential for an international epidemic.

Delivering End-to-End Diagnostics Solutions

Dennis Flannelly, Vice President of PerkinElmer Diagnostics, discusses the company’s exciting new offerings at AACC 2018, including the Vanadis NIPT Solution for non-invasive pre-natal testing.